Showing results (791-800 of 7,008) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|February 11, 2012
Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancerSophie Iochmann, Stéphanie Lerondel, Claire Bléchet, et al.Lung Cancer (Amsterdam, Netherlands)|February 14, 2012
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neuJ De Grève, E Teugels, C Geers, et al.Lung Cancer (Amsterdam, Netherlands)|March 17, 2012
Retrospective study of erlotinib in patients with advanced squamous lung cancerJeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, et al.Lung Cancer (Amsterdam, Netherlands)|January 21, 2012
Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studiesXia Xue, De-Fu Sun, Cui-Cui Sun, et al.Lung Cancer (Amsterdam, Netherlands)|December 3, 2011
Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutationKenichi Suda, Kenji Tomizawa, Hirotaka Osada, et al.Lung Cancer (Amsterdam, Netherlands)|December 14, 2011
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancerMark J C Nuijten, Javier de Castro Carpeño, Christos Chouaid, et al.Lung Cancer (Amsterdam, Netherlands)|December 14, 2011
Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: a comprehensive study of Caucasian non-smokersPierre-Alexandre Just, Aurélie Cazes, Anne Audebourg, et al.Lung Cancer (Amsterdam, Netherlands)|January 10, 2012
History of tuberculosis as an independent prognostic factor for lung cancer survivalMarlies E Heuvers, Joachim G J V Aerts, Joost P Hegmans, et al.Lung Cancer (Amsterdam, Netherlands)|September 28, 2011
Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanningPepijn Brocken, Berni A B Kiers, Monika G Looijen-Salamon, et al.Lung Cancer (Amsterdam, Netherlands)|March 16, 2012
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lungJin Gu Lee, Sewha Kim, Hyo Sup ShimPageof 701